JCAR014 and Durvalumab in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab in Patients With HER-2 Positive Metastatic Breast Cancer Receiving Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Durvalumab (MEDI4736) in Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Adjuvant Durvalumab for Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA